Cargando…

Factors associated with HIV and HCV infection among individuals with a history of injection drug use in Baltimore

Detalles Bibliográficos
Autores principales:	Severtson, SG, Graham, CM, Mitchell, M, Floyd, L, Latimer, WW
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716881/ http://dx.doi.org/10.1186/1742-4690-3-S1-P59

Ejemplares similares

Factors associated with HIV and hepatitis C infection among regular and non-regular injection drug users in Baltimore
por: Graham, CM, et al.
Publicado: (2006)

The moderating influence of cognitive performance on risk awareness to predict HIV/AIDS risk-taking behaviors
por: Mitchell, MM, et al.
Publicado: (2006)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Mitral valve endocarditis in an IV ethnobotanical drug user coinfected with HIV-HCV
por: Popa, Ionut, et al.
Publicado: (2014)

Low reduction of HCV-RNA level at week 4 in HIV-1 infected patients with acute HCV Infection
por: Vincent, A, et al.
Publicado: (2012)

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment
por: Chantry, AS, et al.
Publicado: (2014)

Prevalence of HCV, HBV and HIV infections in patients and staff of haemodialysis unit
por: Palanisamy, Saraswathy, et al.
Publicado: (2012)

Pilot trial of oral therapeutic HIV vaccine, V-1 Immunitor, on HIV and HIV/HCV patients in Russia
por: Bourinbaiar, Aldar, et al.
Publicado: (2010)

Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV
por: Deloof, ACA, et al.
Publicado: (2010)

The study of hepatitis B surface antigen and anti-HCV in HIV infected patients
por: Girish, N, et al.
Publicado: (2012)

Transmission of HIV, HBV, HCV in health settings: an anthropological approach on hygiene in Cambodia
por: Hancart-Petitet, Pascale, et al.
Publicado: (2011)

The research on female partners of injecting drug users-gender aspect and risk of HIV
por: Grbic, Miljana, et al.
Publicado: (2012)

Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
por: Euler, Z, et al.
Publicado: (2012)

Role of HCV infection in the development of carotid atherosclerosis in a cohort of HIV-infected patients
por: Ferrara, S, et al.
Publicado: (2010)

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV
por: Fernández-Montero, JV, et al.
Publicado: (2010)

Immune response characterization in HIV/HCV co-infected patients of medicine tropical foundation
por: Malheiro, Adriana, et al.
Publicado: (2010)

The results of a study on the prevalence of HIV, HCV and HBV genotypes in some regions of Ukraine
por: Yurchenko, et al.
Publicado: (2012)

Behavioral factors associated with HCV and HIV co-infection in residents of São Paulo, Brazil
por: Farias, Norma, et al.
Publicado: (2012)

New drug interactions in HIV and HCV
por: Back, David
Publicado: (2012)

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
por: Manfredi, Roberto, et al.
Publicado: (2010)

Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
por: Tossonian, HK, et al.
Publicado: (2010)

Services integration for injection drug users on antiretroviral therapy for management of HIV epidemic in Estonia
por: Laisaar, Kaja-Triin, et al.
Publicado: (2010)

Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients
por: Macías, J, et al.
Publicado: (2010)

Viral variability study in follow-up sera from HIV-HBV-HCV coninfected patients
por: Taffon, Stefania, et al.
Publicado: (2010)

First Molecular surveillance report of HIV in injecting drug users and female sex workers in Mexico
por: Eyzaguirre, Lindsay M, et al.
Publicado: (2006)

Non-injected illicit drugs and alcohol and HIV-related high-risk sexual behaviors in a street-recruited sample of non-injecting drug users in New York City
por: Mishra, Ashutosh, et al.
Publicado: (2010)

Liver disease progression in HIV/HCV co-infected patients: a role for metalloproteinases and their specific inhibitors
por: Sasongko, Priyo
Publicado: (2006)

Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
por: Demetriou, Victoria L, et al.
Publicado: (2010)

Relying on injection drug users to prevent HIV in Ukraine - follow-up results of peer-driven interventions
por: Datsenko, Oleksandra, et al.
Publicado: (2012)

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon
por: Agyingi, L, et al.
Publicado: (2012)

Effects on insulin sensitivity and hepatic safety of Atazanavir in HCV/HIV coinfected patients versus HIV monoinfected: A prostective 48-week study
por: Meijide, Héctor, et al.
Publicado: (2010)

Changes in immune activation in the T Cell compartments of HIV HCV coinfected patients during PEG IFN RBV treatment
por: Menard, Amélie, et al.
Publicado: (2012)

Molecular epidemiology and genetic analysis of HCV infection in Cyprus within an intravenous drug user study cohort
por: Iacovides, Demetris C, et al.
Publicado: (2012)

Antiviral resistance in HCV strains isolated from Romanian patients with limited treatment options for chronic HCV infection
por: Streinu-Cercel, Anca, et al.
Publicado: (2014)

Development of drug resistance among HIV-1 F1 sub-type patients with treatment failure
por: Temereanca, A, et al.
Publicado: (2010)

HBV and HCV genotypes distribution on the territory of Belarus
por: Gasich, EL, et al.
Publicado: (2012)

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
por: Labarga, P, et al.
Publicado: (2010)

Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
por: Bhatti, L, et al.
Publicado: (2010)

P06-02. High prevalences of HIV, HCV, HBV and Treponema pallidum in male and trans sex workers from Argentina
por: Farías, M dos Ramos, et al.
Publicado: (2009)

Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients
por: Ménard, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q34h034i4ssp9880eihig8jlm1